Search for

    Search Results

    Close

    Chiang Mai Cardiology Conference




    “First drug to significantly improve heart
    failure mortality in over a decade”


    - NOW ALSO in a formula for PROPHYLACTIC TREATMENT – cutting cardiovascular mortality by more than 50%

    New life saving therapy helps people with weak hearts. A groundbreaking international study headed by Danish researchers has been published in the esteemed Journal of The American College of Cardiology, HEART FAILURE.

    In addition to cutting cardiovascular mortality by more than 50%, supplementing elderly people with selenium and coenzyme Q10 improved their quality of life, reduced their risk of disease, and increased their energy levels.

    The KiSel 10 study was published in the International Journal of Cardiology

    Get all the facts:
    Moderator: Khunying Mallika Wannakrairot, MD
    Speaker: Prof. Urban Alehagen
    Date: 10 September 2016, Saturday
    Venue: Shangri-La Hotel, Chiang Mai
    Location: Floor 1, AUDITORIUM
    Talk: 12:00 - 13:30 hours

    Professor Urban Alehagen


    Department of Cardiology, University Hospital of Linköping


    Prof Alehagen headed the KiSel-10 research team

     

    Medical Education: Specialist in Internal Medicine 1992, Specialist in Cardiology 1995, Accepted for PhD studies 1995, PhD
    exam 2003, Associate Professor in Cardiology 2009, Professor in Cardiology 1st of June 2016
    Thesis: Heart Failure in Primary Care. Special emphasis in Natriuretic Peptides in the Elderly

    RSVP/Reserved Seating: Stop by Pharma Nord SEA booth 49
    Office telephone number
    02 279 6860 – 1
    info@pharmanordsea.co.th